Active, not recruiting
Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome
NCT06050122
- Conditions
- Abnormalities, Multiple, Basal Cell Nevus Syndrome, Bone Cysts, +19 more
- Locations
-
- Northwest Arkansas Clinical Trials Center Rogers, Arkansas, United States
- Center for Dermatology Clinical Research Fremont, California, United States
- University of California Los Angeles (UCLA) - Center for Inflammatory Bowel Diseases - Westwood Location Los Angeles, California, United States
- The Dermatology Center of Newport Newport Beach, California, United States